Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
ACC 2018: Canagliflozin & heart failure in type 2 diabetes

Gemma Figtree

Watch time: 3m 13s
ACC 2018: MOMENTUM 3 Trial - Multicenter Study of MagLev Technology

Mandeep Mehra

Watch time: 8m 26s

Iqbal Malik, Horst Sievert, Lars Søndergaard, et al

Watch time: 22m 51s (31 videos)
30-Day Risk Standardized Mortality discusses with Ambarish Pandey

Ambarish Pandey

Watch time: 4m 22s
CRY 2017: ECG Indices of Cardiomyopathy

Nabeel Sheikh

Watch time: 12m 55s
CRY 2017: Exercise Recommendations - Athletes With Cardiomyopathy

Michael Papadakis

Watch time: 12m 58s

Elijah R Behr

Watch time: 15m 17s
ESC 2017: Baroreflex Activation Therapy for HF

Stefan Anker

Watch time: 55s
HFA 2017 by PD DR. Christian Veltmann

Christian Veltmann

Watch time: 20m 41s
Screening - patient selection at risk for sudden cardiac death - HFA 2017

Johannes Sperzel

Watch time: 14m 19s
Patient treatment pathways - EHRA 2017

Serge Boveda

Watch time: 15m 6s
Utility of remotely managed patient - EHRA 2017

Jan Steffel

Watch time: 10m 27s
Treating Diabetes In Heart Failure Patients At EASD 2017 Marc Evans

Marc Evans

Watch time: 3m 57s
Risk For Heart Failure Modulate The Effectiveness Of Empagliflozin ? with Javed Butler

Javed Butler

Watch time: 5m 13s
Routine Vs. Aggressive Upstream Rhythm Control - Isabelle Van Gelder

Isabelle C Van Gelder

Watch time: 11m 58s
Catheter Ablation Vs. Conventional Treatment - Nassir Marrouche

Nassir F Marrouche, Afzal Sohaib

Watch time: 13m 54s